Catalogue number
PRO-513
Introduction
Mycoplasma pneumonia is part of the atypical pneumonia subtype which is caused by the bacteria M. pneumoniae. Mycoplasma pneumonia affects individuals younger than 40. It makes up 15 - 50% of all pneumonia cases in *****s and especially in school-aged children. People at great risk for mycoplasma pneumonia comprise of those living or working in busy areas such as schools and homeless shelters, although many people who contract mycoplasma pneumonia have no identifiable risk factor. P1, P30, and P116 of mycoplasma pneumonia membrane proteins have been recognized as adhensive factors, P1 is considered as a main adhension protein of the organism colonization.
Description
The Recombinant Mycoplasma Pneumoniae P116 was expressed in E. coli. having an Mw of 116 kDa. P116 is fused to a GST-Tag.
Source
E.Coli
Purification Method
The recombinant fusion protein was purified by GSH affinity chromatography technique.
Physical Appearance
Streile filtered colorless solution.
Formulation
Mycoplasma Pneumoniae P116 is formulated in 1xPBS and 25mM arginine.
Stability
Upon arrival, Store at -20°C.
Please prevent freeze-thaw cycles.
Purity
Greater than 95% as determined by 12% PAGE (Coomassie staining).
Applications
Can be used for?lateral flow product, ELISA assay and vaccine development.
Safety Data Sheet
Usage
ProSpecs products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
